As of October 1, 2026, Bayer’s proposed $7.25 billion Roundup class settlement still awaits final approval. On September 14, 2026, Judge Timothy Boyer of the St. Louis circuit court heard arguments from supporters and objectors but did not rule from the bench. A decision is expected at a later date. Registration and claim submission open only after final approval, and the June 4, 2026 opt-out deadline has already passed.
This follows the U.S. Supreme Court’s 7-2 decision in Monsanto v. Durnell on June 25, 2026, which held that Missouri state law cannot override EPA labeling requirements. We checked for anything newer and found no final-approval ruling yet.
Last updated: October 2026
The Roundup lawsuit is one of the largest mass tort cases in American legal history, and it is still very much alive in 2026. If you or someone you love used Roundup weed killer and later developed cancer, you may have a right to financial compensation.
Bayer, the German pharmaceutical giant that now owns Monsanto, has already paid out billions to settle Roundup claims. But thousands of cases remain active. New claims are still being filed.
This article covers everything you need to know. Who qualifies. How much settlements pay. What your deadlines are. And exactly how to get started in 2026.
Roundup Lawsuit 2026: What You Need to Know Right Now
The Roundup lawsuit in 2026 is still an active legal matter with thousands of pending claims and ongoing litigation across federal and state courts.
Bayer has spent years trying to close the book on Roundup litigation. It set up a massive settlement fund, negotiated with plaintiff attorneys, and resolved the majority of filed cases. But the legal fight is far from over.
Courts are still seeing new filings. Newly diagnosed plaintiffs are entering the system. And Bayer is still fighting cases that did not settle under earlier programs.
Key facts for 2026:
- Bayer has allocated over $11 billion toward Roundup lawsuit settlements
- The core legal claim: the herbicide’s active ingredient, glyphosate, causes cancer
- The primary cancer linked to Roundup is non-Hodgkin lymphoma
- Claims can still be filed in most states in 2026
The situation right now is that claimants who missed earlier settlement windows or who were diagnosed after initial funds were distributed are entering a new phase of litigation. This wave of newer cases may head toward individual jury trials.
| Status Item | 2026 Update |
|---|---|
| Active litigation | Yes, in multiple states |
| New claims accepted | Yes, for recent diagnoses |
| Settlement fund | Still operating, some portions closed |
| Jury trials | Ongoing for unresolved cases |
| Primary defendant | Bayer AG (successor to Monsanto) |
What Is the Roundup Lawsuit and How Did It Start
The Roundup lawsuit is a mass tort legal action against the makers of Roundup weed killer, alleging that exposure to glyphosate causes cancer, specifically non-Hodgkin lymphoma.
Roundup has been one of the world’s most widely used herbicides for decades. Farmers spray it on crops. Homeowners use it on lawns. Golf courses, municipalities, and landscapers have relied on it for years.
The legal trouble began in earnest when the International Agency for Research on Cancer, a branch of the World Health Organization, classified glyphosate as “probably carcinogenic to humans” in 2015. That classification opened the floodgates.
The first major trial verdict came in August 2018. Dewayne Johnson, a California school groundskeeper who regularly used Roundup, won a $289 million verdict against Monsanto. A jury found the company failed to warn him about cancer risks.
Two more landmark verdicts followed quickly:
- Edwin Hardeman won $80 million in March 2019 in federal court
- Alva and Alberta Pilliod won a combined $2 billion in May 2019 (later reduced on appeal)
These early victories sparked a flood of lawsuits. By the time Bayer acquired Monsanto in 2018, it had inherited a legal catastrophe already building for years.
Key Takeaway: The Roundup lawsuit started after a 2015 cancer classification and exploded after three major jury wins between 2018 and 2019, ultimately forcing Bayer to pay billions.
Bayer Roundup Lawsuit: The Corporate Story Behind the Claims
Bayer AG became the central defendant in the Roundup lawsuit when it completed its $63 billion acquisition of Monsanto in June 2018.
That timing was, to put it plainly, terrible. Bayer bought Monsanto just as the first Roundup trial was heading to verdict. Within months, the acquisition that was supposed to make Bayer an agricultural powerhouse turned into one of the most expensive corporate legal disasters in recent memory.
Monsanto had manufactured and sold Roundup since 1974. The company had internal documents going back decades discussing glyphosate’s potential risks. Plaintiff attorneys used those documents to argue that Monsanto knew about the dangers and chose not to warn the public.
Bayer has consistently denied that Roundup causes cancer. It has pointed to regulatory approvals from the EPA and agencies in other countries as proof of safety. But juries have repeatedly sided with plaintiffs.
By 2020, Bayer announced a $10.9 billion settlement to resolve around 125,000 pending cases. That fund has since grown. The company has also set aside additional billions for future claims.
| Timeline Event | Date |
|---|---|
| Monsanto created Roundup | 1974 |
| IARC classifies glyphosate as probable carcinogen | 2015 |
| Bayer acquires Monsanto | June 2018 |
| First jury verdict (Dewayne Johnson) | August 2018 |
| Bayer announces $10.9 billion settlement | June 2020 |
| Ongoing litigation and new claims | 2026 |
Glyphosate Cancer Lawsuit: What the Science Actually Says
Glyphosate is the active chemical ingredient in Roundup, and the science around its cancer risk has been contested at the highest levels of international research.
The IARC’s 2015 “probably carcinogenic” classification sits at Group 2A. That’s the same category as red meat and working as a hairdresser. It does not mean glyphosate definitely causes cancer. It means the evidence suggests a probable link.
On the other side, the U.S. EPA has repeatedly stated that glyphosate is not likely to be carcinogenic to humans when used as directed. That gap between the IARC and the EPA is at the heart of why Roundup cases are so legally complex.
In 2026 courtrooms, both sides bring expert witnesses to battle over this divide. Plaintiff attorneys rely heavily on epidemiological studies showing higher rates of non-Hodgkin lymphoma among agricultural workers with high glyphosate exposure. Defense attorneys point to EPA conclusions and meta-analyses showing no definitive causal link.
The Ninth Circuit Court of Appeals ruled in 2021 that federal law did not automatically shield Monsanto from state failure-to-warn claims. That ruling kept the litigation alive and is a key reason cases continue in 2026.
Scientists have also identified potential mechanisms by which glyphosate could disrupt DNA repair and trigger oxidative stress in cells, adding biological plausibility to the epidemiological findings.
What Cancers Qualify for the Roundup Lawsuit
Non-Hodgkin lymphoma is the primary cancer that qualifies for the Roundup lawsuit, but several specific subtypes and related blood cancers may also be eligible.
Think of non-Hodgkin lymphoma as an umbrella term. Under it sit dozens of specific subtypes, some more aggressive than others. Courts and settlement administrators have recognized several of these as qualifying diagnoses.
Cancers that may qualify:
- Non-Hodgkin lymphoma (all subtypes, including B-cell and T-cell)
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Marginal zone lymphoma
- Mantle cell lymphoma
- Chronic lymphocytic leukemia (CLL) / Small lymphocytic lymphoma (SLL)
- Hairy cell leukemia
Hodgkin lymphoma typically does not qualify. Most leukemia subtypes other than CLL do not qualify either, though some cases have been argued successfully.
The diagnosis must be confirmed through pathology reports and medical records. The type of lymphoma matters because settlement tiers and payout amounts often differ based on the specific subtype and its severity.
| Cancer Type | Qualifies | Notes |
|---|---|---|
| Non-Hodgkin lymphoma (all subtypes) | Yes | Primary qualifying diagnosis |
| Diffuse large B-cell lymphoma | Yes | Most common qualifying subtype |
| Follicular lymphoma | Yes | Second most common |
| CLL / SLL | Yes | Blood cancer variant recognized |
| Hodgkin lymphoma | Generally No | Different disease pathway |
| Most leukemias | Generally No | Exceptions exist for CLL |
Key Takeaway: Non-Hodgkin lymphoma is the core qualifying cancer for the Roundup lawsuit, covering multiple subtypes, with diagnosis confirmation through medical records being non-negotiable.
Who Qualifies for the Roundup Lawsuit in 2026
You may qualify for the Roundup lawsuit if you were diagnosed with non-Hodgkin lymphoma or a related blood cancer and had significant exposure to Roundup herbicide before your diagnosis.
Qualifying is not simply about having used Roundup once. Courts and settlement programs look at a combination of factors. Think of it like a scoring system where exposure duration, frequency, and the connection between your exposure and your diagnosis all matter.
General qualifying criteria:
- Diagnosed with non-Hodgkin lymphoma or a recognized subtype
- Used Roundup or another glyphosate-based herbicide personally
- Exposure occurred in a professional or residential setting
- Exposure preceded the cancer diagnosis
- Diagnosis occurred after a reasonable latency period post-exposure
- Your statute of limitations has not expired in your state
Family members of someone who died from qualifying cancer may also file wrongful death claims.
Agricultural workers, landscapers, groundskeepers, gardeners, golf course workers, and people who regularly used Roundup on residential properties are among the most common claimants.
| Qualifying Factor | Requirement |
|---|---|
| Cancer diagnosis | Non-Hodgkin lymphoma or recognized subtype |
| Exposure type | Roundup or glyphosate-based product |
| Exposure setting | Occupational or residential use |
| Exposure duration | Regular or repeated use (not a one-time event) |
| Timing | Exposure preceded diagnosis |
| Filing status | Within statute of limitations for your state |
Roundup Lawsuit Eligibility Requirements: The Full Breakdown
Roundup lawsuit eligibility comes down to four core pillars: a qualifying diagnosis, documented exposure history, a clear timeline showing exposure came before the cancer, and filing within your state’s legal deadline.
The medical records piece is critical. You need pathology reports confirming the specific type of lymphoma. Medical records showing when you were diagnosed are essential for establishing your timeline.
The exposure documentation is the trickier part. Most people don’t keep receipts for herbicide purchases from five or ten years ago. But other evidence works: neighbor statements, employer records showing Roundup use, photographs, purchasing histories from home improvement stores, or records from a municipality or employer.
Eligibility checklist:
- Confirmed diagnosis of non-Hodgkin lymphoma or qualifying subtype (pathology report required)
- Direct personal exposure to Roundup or glyphosate-based product
- Exposure occurred before diagnosis date
- No prior settlement or release of claims against Monsanto or Bayer
- Filing within your state’s statute of limitations (typically 2 to 3 years from diagnosis)
- You are the injured person OR the legal representative of a deceased qualifying individual
Pre-existing health conditions do not automatically disqualify you. Many lymphoma patients have other conditions. What matters is whether glyphosate exposure was a contributing factor.
Key Takeaway: You need a confirmed lymphoma diagnosis, documented glyphosate exposure history, a clear timeline, and a filing within your state’s statute of limitations to meet Roundup lawsuit eligibility requirements.
Roundup Lawsuit Settlement Amount: What to Expect
Roundup lawsuit settlement amounts vary widely, but most individual settlements have ranged from $5,000 to over $250,000, with severe cases reaching into the millions.
That range is broad because no two cases are identical. Bayer and settlement administrators use a point-based scoring system to evaluate each claim. The system considers the type of cancer, its severity, the extent of exposure, the plaintiff’s age, and other injury factors.
Factors that increase your settlement value:
- More aggressive cancer subtype (e.g., diffuse large B-cell lymphoma)
- Higher stages of cancer at diagnosis (Stage 3 or 4)
- Longer duration of Roundup exposure
- Occupational use with daily or near-daily contact
- Younger age at diagnosis
- Stronger medical documentation
- Death of plaintiff (wrongful death claims often settle higher)
Factors that can reduce your settlement value:
- Minimal or sporadic exposure history
- Less severe cancer subtype
- Early-stage diagnosis at time of treatment
- Weak medical documentation
- Significant pre-existing health conditions
| Claim Type | Estimated Range |
|---|---|
| Mild exposure, less severe cancer | $5,000 to $40,000 |
| Moderate exposure, moderate diagnosis | $40,000 to $150,000 |
| Heavy occupational exposure, serious cancer | $150,000 to $500,000+ |
| Death from qualifying cancer (wrongful death) | $250,000 to $1,000,000+ |
| Exceptional cases (high-profile jury verdicts) | $1,000,000+ |
Roundup Lawsuit Average Settlement Per Person
The average Roundup lawsuit settlement per person has been estimated at roughly $160,000 to $180,000 based on the structure of Bayer’s main settlement fund, though actual payouts vary significantly by claim tier.
This average comes from dividing Bayer’s total allocation by the number of cases it resolved. In practice, that math overstates what most people receive. The largest verdicts and highest-tier settlements pull the average up. Many individual claimants receive far less.
The settlement program Bayer used for its bulk resolution included a point-based matrix. Plaintiffs were scored. Higher scores meant higher payouts. The system was designed to be efficient for Bayer, not necessarily generous to individuals.
It’s worth understanding that the “average” number circulates heavily in media. It comes from dividing roughly $10.9 billion across around 95,000 to 125,000 cases. The math produces a misleading average.
Real-world settlement breakdown:
- The majority of claimants with valid but lower-tier claims received $10,000 to $80,000
- Mid-tier claimants with stronger evidence received $80,000 to $250,000
- High-tier claimants with strong cases and severe injuries received significantly more
- Attorney fees (typically 25% to 40% of settlement) reduce the net amount
| Claim Tier | Approx. Payout Before Attorney Fees |
|---|---|
| Tier 1 (baseline eligibility) | $10,000 to $40,000 |
| Tier 2 (moderate strength) | $40,000 to $150,000 |
| Tier 3 (strong case, severe injury) | $150,000 to $500,000 |
| Tier 4 (exceptional, death cases) | $500,000 to $1,000,000+ |
Bayer Settlement Fund: Where the Money Comes From
The Bayer settlement fund for Roundup lawsuits was established in June 2020 when Bayer AG announced it would set aside approximately $10.9 billion to resolve existing Roundup claims.
That initial number has grown. Bayer has since increased allocations and set aside additional funds to handle future claimants. Total amounts set aside for Roundup litigation across all programs have surpassed $11 billion, with additional reserves for cases still in litigation.
The fund was not a class action settlement. It was a mass resolution of individual claims. Each plaintiff’s case was evaluated separately using a scoring matrix. This is a key distinction from a traditional class action where everyone gets the same amount.
Bayer also established a separate fund for future claimants, including people diagnosed after the initial settlement program closed. The terms and payout levels for this future fund have been subject to ongoing legal disputes.
Part of the 2020 deal included $1.25 billion specifically reserved for future claimants who had not yet filed. Courts raised concerns about whether this adequately protected future plaintiffs’ rights. That portion of the program faced legal challenges that continued into 2026.
Key Takeaway: Bayer’s settlement fund exceeds $11 billion, but it operates as a tiered individual claim system, not a flat payout for everyone, meaning your specific case facts directly determine how much you receive.
How to File a Roundup Lawsuit in 2026
Filing a Roundup lawsuit in 2026 starts with gathering your medical records confirming your cancer diagnosis and documenting your history of Roundup exposure.
The process is not like filing a small claims form. Roundup cases are individual personal injury lawsuits handled by plaintiff attorneys, typically on a contingency fee basis. That means you pay nothing upfront. The attorney takes a percentage of your settlement if you win.
Step-by-step filing process:
- Confirm your diagnosis: Obtain pathology reports and medical records confirming non-Hodgkin lymphoma or a qualifying subtype
- Document your exposure: Collect any evidence of Roundup use (receipts, employer records, witness statements, purchase histories)
- Consult a plaintiff attorney: Most law firms handling mass torts offer free consultations
- Sign a retainer agreement: This formalizes the attorney-client relationship on a contingency basis
- Attorney files your claim: The attorney files your lawsuit or registers your claim with the appropriate settlement program or court
- Claim evaluation: Your case is scored or evaluated based on documented evidence
- Settlement or trial: Most cases settle; some proceed to jury trials if settlement is not reached
The attorney handles virtually everything after Step 3. Your job is to provide documentation and respond to requests for additional information.
Roundup Lawsuit Filing Deadline 2026: Do Not Miss This
The Roundup lawsuit filing deadline in 2026 depends on the statute of limitations in your specific state, which typically ranges from 2 to 3 years from the date of your cancer diagnosis or the date you knew Roundup may have caused it.
Statutes of limitations are strict. Miss the deadline and your case is gone. No settlement. No trial. No compensation.
This is one area where acting quickly is genuinely important. Some states have shorter windows. Others have discovery rules that extend the deadline to when you first connected Roundup to your illness, which may be later than your diagnosis date.
State-by-state deadline examples (approximate):
| State | Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Florida | 4 years from injury |
| New York | 3 years from injury |
| Texas | 2 years from injury |
| Illinois | 2 years from injury |
| Ohio | 2 years from injury |
| Pennsylvania | 2 years from injury |
If you were diagnosed years ago and have not yet filed, the clock may already be running out. The discovery rule may extend your window, but only if you can show you did not reasonably know about the Roundup connection earlier.
Key Takeaway: Your Roundup lawsuit filing deadline is set by your state’s statute of limitations, typically 2 to 4 years from diagnosis or discovery, making prompt action essential if you have not yet filed.
Can I Still File a Roundup Lawsuit in 2026
Yes, you can still file a Roundup lawsuit in 2026 if your statute of limitations has not expired and you have a qualifying cancer diagnosis connected to Roundup exposure.
Many people assume that because Bayer’s major settlement program made headlines in 2020, the litigation is over. It is not. Thousands of cases remain in active litigation. New cases continue to be filed.
People who were diagnosed recently, those whose diagnosis came in 2023, 2024, or 2025, may be well within their filing window. The statute of limitations runs from the date of diagnosis or from when you could reasonably have connected your cancer to Roundup. A diagnosis from 2024 in a two-year statute state would mean a 2026 deadline is imminent.
People who previously filed and had their claims denied, or who were excluded from earlier settlement programs for procedural reasons, may have options to refile or appeal depending on the circumstances.
Courts are still actively accepting new Roundup cases. The MDL (Multi-District Litigation) case No. MDL 2741 in the Northern District of California remains an active vehicle for federal claims. State courts in California, Missouri, Delaware, and elsewhere continue to handle state-filed Roundup lawsuits.
If you are unsure whether your window is still open, the only way to know for certain is to speak with a plaintiff attorney who handles mass tort cases.
Roundup Lawsuit Opt Out Explained
Opting out of the Roundup lawsuit settlement means choosing not to accept the offered settlement amount and instead pursuing your case through an individual jury trial.
When Bayer structured its settlement programs, some claimants were given the option to accept a settlement offer or opt out and continue their individual case. This is a significant decision with real tradeoffs.
Reasons to consider opting out:
- Your case is unusually strong (severe cancer, extremely high exposure, compelling documentary evidence)
- The settlement offer you received feels inadequate given your damages
- You believe a jury trial could produce a far higher verdict
- You are willing to wait longer and accept more risk for potentially higher compensation
Reasons to consider accepting a settlement:
- Certain, faster payment vs. the uncertainty of a jury trial
- Trials can take years and the outcome is never guaranteed
- Even after a large jury verdict, appeals can reduce the amount significantly
- Attorney fees and litigation costs are lower in settlements
Think of it like accepting a job offer versus holding out for a better one. The bird in hand is real. The better offer might come, or it might not.
Most claimants in mass tort cases accept settlements. A small percentage opt out and go to trial. Some of those trial outcomes have been spectacular for plaintiffs. Others have not.
| Decision | Pros | Cons |
|---|---|---|
| Accept settlement | Fast, certain payment | May be less than trial value |
| Opt out for trial | Potentially higher award | Risk of loss, long wait |
Roundup Lawsuit Status and Latest Updates
The Roundup lawsuit in 2026 remains one of the most active mass tort cases in the U.S. court system, with pending cases in federal MDL court and multiple state jurisdictions.
Bayer’s legal strategy in recent years has shifted. The company initially fought aggressively for a Supreme Court review, hoping the nation’s highest court would rule that EPA approval shielded it from state-law failure-to-warn claims. The Supreme Court declined to take the case in 2024, leaving Bayer exposed to continued litigation.
That refusal was significant. It confirmed that Roundup plaintiffs can still pursue state-law claims based on failure to warn, even though the EPA did not require cancer warnings on Roundup labels.
2026 status summary:
- Federal MDL 2741 in the Northern District of California: Active, with new cases being added
- State court cases: Active in California, Missouri, Delaware, New Jersey, and others
- Bayer’s ongoing settlement programs: Some portions active, some closed
- New claimant intake: Still open for recent diagnoses
- Jury trials: Scheduled and ongoing throughout 2026
Bayer has publicly stated it is exploring potential future legislative solutions, such as a federal standard for glyphosate warnings that would preempt state lawsuits. This effort has not succeeded as of 2026.
Key Takeaway: The Roundup lawsuit is fully active in 2026, with Bayer’s Supreme Court preemption bid rejected, keeping state failure-to-warn claims alive and thousands of cases still moving through courts.
How Long Does the Roundup Lawsuit Take to Settle
Most Roundup lawsuits that are part of Bayer’s settlement programs take between 6 months and 2 years from the time of filing to receiving payment.
Cases that go to jury trial take longer. Individual trials can run 3 to 5 years or more from filing to verdict, especially when appeals are factored in.
The settlement timeline is faster because the evaluation is administrative rather than adversarial. Your attorney files the claim, the claims administrator reviews your evidence, scores your case, and issues an offer. Negotiations may follow. Once accepted, payment processing takes additional weeks to months.
Approximate timeline for settled cases:
| Phase | Time Estimate |
|---|---|
| Initial consultation and retainer | 1 to 4 weeks |
| Evidence gathering and claim preparation | 1 to 3 months |
| Claim filing and submission | 1 to 2 weeks |
| Claims administrator review | 3 to 12 months |
| Settlement offer and negotiation | 1 to 3 months |
| Payment processing after acceptance | 4 to 12 weeks |
| Total approximate timeline | 6 months to 2 years |
For cases heading toward trial, the timeline extends considerably. Bellwether trial scheduling, discovery, expert witness depositions, motions, and appeals all add time.
Patience is unavoidable in mass tort litigation. The scale of these cases means administrative processes move slowly even when everything goes smoothly.
Frequently Asked Questions
How much money can I get from the Roundup lawsuit settlement?
Most Roundup lawsuit settlements pay between $10,000 and $500,000, with the amount depending on the severity of your cancer, the strength of your exposure evidence, and your claim tier.
Cases involving death from qualifying cancer or extremely severe injuries can exceed $1 million.
Attorney fees of 25% to 40% are typically deducted from the gross settlement before you receive payment.
What cancers qualify for the Roundup weed killer lawsuit?
Non-Hodgkin lymphoma is the primary qualifying cancer for the Roundup lawsuit, covering subtypes including diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma.
Chronic lymphocytic leukemia and hairy cell leukemia may also qualify in many cases.
Hodgkin lymphoma and most other cancers typically do not meet the qualifying criteria.
Is it too late to file a Roundup lawsuit in 2026?
It is not too late to file a Roundup lawsuit in 2026 if your state’s statute of limitations has not expired.
Most states give you 2 to 4 years from your diagnosis date or from when you discovered the Roundup connection.
If you were diagnosed in 2023, 2024, or 2025, you likely still have time, but you should consult with an attorney immediately to confirm your specific deadline.
How do I prove I was exposed to Roundup for my lawsuit?
You can prove Roundup exposure through a combination of purchase receipts, employer records, witness statements, store loyalty card purchase histories, and personal use records.
Perfect documentation is not required.
Attorneys work with clients to build exposure evidence from whatever records exist, including sworn statements from the plaintiff and witnesses.
How long will it take to receive a Roundup lawsuit settlement payment?
Most Roundup claimants receive payment within 6 months to 2 years from the time their claim is filed, depending on which settlement program their case falls under.
The review and scoring process takes several months after filing.
Cases that go to trial rather than settling can take 3 to 5 years or longer before any payment is received.
Where Things Stand and What You Should Do Now
The Roundup lawsuit is not history. It is an active legal battle with real money still being paid to real people in 2026. If you or a family member developed non-Hodgkin lymphoma after using Roundup, the window to act is open but not unlimited.
Gather your medical records now. Document your exposure history as thoroughly as you can. Speak with a plaintiff attorney who handles mass tort cases. The consultation is free and the attorney only gets paid if your case settles or wins at trial.
Your statute of limitations is a hard stop. The law will not make exceptions because you waited too long to file. If there is any chance you qualify, find out now while you still can.
